BIM
TTPH

BlackRock Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

BlackRock Investment Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$596K Sell
7,391
-154
-2% -$12.2K ﹤0.01% 2983
2016
Q3 		$578K Sell
7,545
-11
-0.1% -$881 ﹤0.01% 2973
2016
Q2 		$650K Buy
7,556
+1,388
+23% +$127K ﹤0.01% 2915
2016
Q1 		$571K Buy
6,168
+122
+2% +$12.2K ﹤0.01% 2841
2015
Q4 		$1.21M Buy
6,046
+40
+0.7% +$7.98K ﹤0.01% 2454
2015
Q3 		$896K Sell
6,006
-1,530
-20% -$1.12M ﹤0.01% 2672
2015
Q2 		$7.15M Buy
7,536
+2,258
+43% +$1.85M 0.01% 1223
2015
Q1 		$3.87M Buy
5,278
+1,544
+41% +$1.16M 0.01% 1559
2014
Q4 		$2.97M Buy
3,734
+535
+17% +$288K ﹤0.01% 1744
2014
Q3 		$1.28M Buy
3,199
+34
+1% +$9.11K ﹤0.01% 2336
2014
Q2 		$854K Buy
3,165
+1,215
+62% +$261K ﹤0.01% 2716
2014
Q1 		$425K Buy
1,950
+54
+3% +$15K ﹤0.01% 3036
2013
Q4 		$513K Buy
1,896
+278
+17% +$66.3K ﹤0.01% 2938
2013
Q3 		$368K Buy
1,618
+197
+14% +$34.4K ﹤0.01% 3053
2013
Q2 		$200K Buy
+1,421
New +$225K ﹤0.01% 3164

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock Investment Management's TTPH Position: Q4 2016 in Review

BlackRock Investment Management reduced its Tetraphase Pharmaceuticals, Inc. (TTPH) stake by 2% in Q4 2016, selling an estimated $12.2K and leaving 7,391 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

BlackRock Investment Management first reported a position in TTPH in Q2 2013 and has held it in 15 quarters since. The position peaked at $7.15M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.

  • BlackRock Investment Management held 7,391 shares of Tetraphase Pharmaceuticals, Inc. worth $596K as of Q4 2016.
  • BlackRock Investment Management sold 154 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $12.2K.
  • Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2983 holding.
  • BlackRock Investment Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Tetraphase Pharmaceuticals, Inc. position peaked at $7.15M in Q2 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.